{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T18:17:50Z","timestamp":1783448270727,"version":"3.55.0"},"reference-count":75,"publisher":"Bioscientifica","issue":"1","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":165,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,1]]},"abstract":"<jats:sec>\n                    <jats:title>Graphical abstract<\/jats:title>\n                    <jats:p\/>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Hyperthyroidism adversely affects quality of life (QoL), encompassing physical, mental and social functioning and well-being. Patients with hyperthyroidism often complain of anxiety, physical symptoms and tiredness. Concurrent thyroid eye disease (TED) further reduces QoL. With treatment of hyperthyroidism, QoL improves. Symptoms of hyperthyroidism, overall QoL and tiredness are among the domains that improve with a high effect size. Notwithstanding, the overall reduction in QoL persists compared to a matched general population, which seems to relate to residual tiredness, mental fatigue and concerns about levothyroxine substitution, ophthalmological symptoms and weight gain. Common factors contributing to reduced QoL in the long term have been described and include a high prevalence of thyroid dysfunction, the psychological burden of chronic illness, TED, possible inability of levothyroxine replacement to restore euthyroidism in all tissues, and central nervous system residual damage and\/or dysfunction. The aetiology and treatment modality for hyperthyroidism may also play a role. In addition, a recently highlighted contributor and predictor of poor QoL is excessive weight gain, which given the global epidemic of obesity, mandates further attention. Regarding newer therapies for hyperthyroidism, notably radiofrequency ablation and molecular targeted immunotherapies, there is a dearth of objective data on QoL. New or improved tools for assessing QoL may be needed to better capture all concerns of these patients. There is a need for randomized controlled studies to guide practitioners regarding which pharmacological or non-pharmacological interventions offer the best long-term QoL outcomes in hyperthyroidism. Anti-obesity medications to mitigate weight gain could also be considered for such patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Plain language summary<\/jats:title>\n                    <jats:p>Thyroid overactivity (hyperthyroidism) worsens patients\u2019 QoL, which usually improves after treatment. However, QoL is not completely restored for many patients. The reasons are multiple, including excessive weight gain. New approaches in treating hyperthyroidism are needed to address the long-term effects on QoL.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/ec-25-0645","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T10:37:56Z","timestamp":1767609476000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-10","source":"Crossref","is-referenced-by-count":2,"title":["PERSPECTIVE: Prioritizing quality of life in the management of hyperthyroidism: an expert clinical perspective"],"prefix":"10.1530","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2282-0192","authenticated-orcid":true,"given":"Angelos","family":"Kyriacou","sequence":"first","affiliation":[{"name":"1"},{"name":"2"},{"name":"3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1510-4702","authenticated-orcid":true,"given":"Nadia","family":"Sawicka-Gutaj","sequence":"additional","affiliation":[{"name":"4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akheel A","family":"Syed","sequence":"additional","affiliation":[{"name":"3"},{"name":"5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros","family":"Perros","sequence":"additional","affiliation":[{"name":"6"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"key":"2026070713510445200_bib1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrendo.2018.18","article-title":"Global epidemiology of hyperthyroidism and hypothyroidism","volume":"14","author":"Taylor","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"2026070713510445200_bib2","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1056\/NEJMra1510030","article-title":"Graves\u2019 disease","volume":"375","author":"Smith","year":"2016","journal-title":"N Engl J Med"},{"key":"2026070713510445200_bib3","first-page":"140","article-title":"World Health Organization quality-of-life scale (WHOQOL-BREF): analyses of their item response theory properties based on the graded responses model","volume":"5","author":"Vahedi","year":"2010","journal-title":"Iran J Psychiatry"},{"key":"2026070713510445200_bib4","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.4081\/hpr.2013.e27","article-title":"Quality of life in chronic disease patients","volume":"1","author":"Megari","year":"2013","journal-title":"Health Psychol Res"},{"key":"2026070713510445200_bib5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1530\/EJE-09-0521","article-title":"Validity and reliability of the novel thyroid-specific quality of life questionnaire, ThyPRO","volume":"162","author":"Watt","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"2026070713510445200_bib6","doi-asserted-by":"crossref","first-page":"e357","DOI":"10.1002\/edm2.357","article-title":"Thyroid disease-specific quality of life questionnaires \u2013 a systematic review","volume":"5","author":"Uslar","year":"2022","journal-title":"Endocrinol Diabetes Metab"},{"key":"2026070713510445200_bib7","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1089\/thy.2016.0044","article-title":"Quality-of-life impairments persist six months after treatment of Graves\u2019 hyperthyroidism and toxic nodular goiter: a prospective cohort study","volume":"26","author":"Cramon","year":"2016","journal-title":"Thyroid"},{"key":"2026070713510445200_bib8","first-page":"1","article-title":"Quality of life in patients with hyperthyroidism: where do we stand?","volume":"8","author":"Vita","year":"2020","journal-title":"Mediterr J Clin Psychol"},{"key":"2026070713510445200_bib9","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.psyneuen.2006.09.012","article-title":"Affective symptoms and cognitive functions in the acute phase of Graves\u2019 thyrotoxicosis","volume":"32","author":"Vogel","year":"2007","journal-title":"Psychoneuroendocrinology"},{"key":"2026070713510445200_bib10","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1365-2796.1996.441788000.x","article-title":"Clinical outcome of radioiodine treatment of hyperthyroidism: a follow-up study","volume":"239","author":"Berg","year":"1996","journal-title":"J Intern Med"},{"key":"2026070713510445200_bib11","doi-asserted-by":"crossref","first-page":"4786","DOI":"10.1210\/jc.2006-0573","article-title":"Positron emission tomography reveals correlations between brain metabolism and mood changes in hyperthyroidism","volume":"91","author":"Schreckenberger","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070713510445200_bib12","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid Association Guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid"},{"key":"2026070713510445200_bib13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000490384","article-title":"2018 European Thyroid Association Guideline for the management of Graves\u2019 hyperthyroidism","volume":"7","author":"Kahaly","year":"2018","journal-title":"Eur Thyroid J"},{"key":"2026070713510445200_bib14","doi-asserted-by":"crossref","first-page":"38","DOI":"10.4274\/mirt.galenos.2024.21548","article-title":"Quality of life outcomes following radioactive lodine 131 therapy in hyperthyroid patients: insights from the thyroid patient-reported outcome questionnaire","volume":"34","author":"Af\u015fin","year":"2025","journal-title":"Mol Imaging Radionuclide Ther"},{"key":"2026070713510445200_bib15","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1210\/jc.2014-1322","article-title":"The thyroid-related quality of life measure ThyPRO has good responsiveness and ability to detect relevant treatment effects","volume":"99","author":"Watt","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070713510445200_bib16","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jss.2014.07.061","article-title":"Improved quality of life in hyperthyroidism patients after surgery","volume":"193","author":"Bukvic","year":"2015","journal-title":"J Surg Res"},{"key":"2026070713510445200_bib17","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/cen.13611","article-title":"Treatment choice, satisfaction and quality of life in patients with Graves\u2019 disease","volume":"88","author":"Conaglen","year":"2018","journal-title":"Clin Endocrinol"},{"key":"2026070713510445200_bib18","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1210\/clinem\/dgad538","article-title":"Outcomes of patients with Graves disease 25 years after initiating antithyroid drug therapy","volume":"109","author":"Meling Stokland","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070713510445200_bib19","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1530\/eje.1.02124","article-title":"Quality of life in patients with benign thyroid disorders. A review","volume":"154","author":"Watt","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"2026070713510445200_bib20","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1172\/JCI118353","article-title":"Replacement therapy for hypothyroidism with thyroxine alone does not ensure euthyroidism in all tissues, as studied in thyroidectomized rats","volume":"96","author":"Escobar-Morreale","year":"1995","journal-title":"J Clin Investig"},{"key":"2026070713510445200_bib21","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1089\/thy.2018.0315","article-title":"Impaired quality of life after radioiodine therapy compared to antithyroid drugs or surgical treatment for Graves\u2019 hyperthyroidism: a long-term follow-up with the thyroid-related patient-reported outcome questionnaire and 36-Item short form health status survey","volume":"29","author":"T\u00f6rring","year":"2019","journal-title":"Thyroid"},{"key":"2026070713510445200_bib22","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1530\/EC-21-0026","article-title":"Determining minimal important change for the thyroid-related quality of life questionnaire ThyPRO","volume":"10","author":"Nordqvist","year":"2021","journal-title":"Endocr Connect"},{"key":"2026070713510445200_bib23","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1089\/thy.2007.0315","article-title":"Consensus statement of the European group on Graves\u2019 orbitopathy (EUGOGO) on management of Graves\u2019 orbitopathy","volume":"18","author":"Bartalena","year":"2008","journal-title":"Thyroid"},{"key":"2026070713510445200_bib24","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1089\/thy.2017.0365","article-title":"Death by suicide in Graves\u2019 disease and Graves\u2019 orbitopathy: a nationwide Danish register study","volume":"27","author":"Ferl\u00f8v-Schwensen","year":"2017","journal-title":"Thyroid"},{"key":"2026070713510445200_bib25","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1530\/EJE-11-0055","article-title":"Quality of life in thyroid eye disease: impact of quality of care","volume":"164","author":"Estcourt","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"2026070713510445200_bib26","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1530\/eje.0.1460751","article-title":"Long-term effects of Graves\u2019 ophthalmopathy on health-related quality of life","volume":"146","author":"Terwee","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"2026070713510445200_bib27","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1530\/EJE-09-0383","article-title":"The patient experience of services for thyroid eye disease in the United Kingdom: results of a nationwide survey","volume":"161","author":"Estcourt","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"2026070713510445200_bib28","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1136\/bjophthalmol-2015-306733","article-title":"PREGO (presentation of Graves\u2019 orbitopathy) study: changes in referral patterns to European group on Graves\u2019 orbitopathy (EUGOGO) centres over the period from 2000 to 2012","volume":"99","author":"Perros","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"2026070713510445200_bib29","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1089\/thy.2019.0085","article-title":"The long-term outcome of treatment for Graves\u2019 hyperthyroidism","volume":"29","author":"Sj\u00f6lin","year":"2019","journal-title":"Thyroid"},{"key":"2026070713510445200_bib30","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/cen.14719","article-title":"Postradioiodine Graves\u2019 management: the PRAGMA study","volume":"97","author":"Perros","year":"2022","journal-title":"Clin Endocrinol"},{"key":"2026070713510445200_bib31","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1089\/thy.2019.0414","article-title":"Impact of a forced dose-equivalent levothyroxine brand switch on plasma thyrotropin: a cohort study","volume":"30","author":"Flinterman","year":"2020","journal-title":"Thyroid"},{"key":"2026070713510445200_bib32","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1089\/thy.2005.15.1279","article-title":"Graves\u2019 disease: a long-term quality-of-life follow up of patients randomized to treatment with antithyroid drugs, radioiodine, or surgery","volume":"15","author":"Abraham-Nordling","year":"2005","journal-title":"Thyroid"},{"key":"2026070713510445200_bib33","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12020-018-1733-y","article-title":"The relationship between quality of life, cognition, and thyroid status in Graves\u2019 disease","volume":"63","author":"Riguetto","year":"2019","journal-title":"Endocrine"},{"key":"2026070713510445200_bib34","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1530\/EJE-15-0395","article-title":"Quality of life in patients with primary hypothyroidism related to BMI","volume":"173","author":"Kelderman-Bolk","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"2026070713510445200_bib35","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1089\/thy.2010.0417","article-title":"Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists","volume":"21","author":"Bahn Chair","year":"2011","journal-title":"Thyroid"},{"key":"2026070713510445200_bib36","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41574-021-00625-8","article-title":"Primary hypothyroidism and quality of life","volume":"18","author":"Heged\u00fcs","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"2026070713510445200_bib37","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1089\/thy.2021.0270","article-title":"Benefits and harms of levothyroxine\/L-triiodothyronine versus levothyroxine monotherapy for adult patients with hypothyroidism: systematic review and meta-analysis","volume":"31","author":"Millan-Alanis","year":"2021","journal-title":"Thyroid"},{"key":"2026070713510445200_bib38","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1210\/jc.2006-0448","article-title":"Thyroxine-triiodothyronine combination therapy versus thyroxine monotherapy for clinical hypothyroidism: meta-analysis of randomized controlled trials","volume":"91","author":"Grozinsky-Glasberg","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070713510445200_bib39","article-title":"6430 SAT-534 evaluating the effectiveness of combined T4 and T3 therapy or desiccated thyroid versus T4 monotherapy in hypothyroidism: a systematic review and meta-analysis","volume":"8","author":"Nassar","year":"2024","journal-title":"J Endocr Soc"},{"key":"2026070713510445200_bib40","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1089\/thy.2023.0066","article-title":"Investigating levothyroxine use and its association with thyroid health in patients with hypothyroidism: a community pharmacy study","volume":"33","author":"Mehuys","year":"2023","journal-title":"Thyroid"},{"key":"2026070713510445200_bib41","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1089\/thy.2020.0515","article-title":"New formulations of levothyroxine in the treatment of hypothyroidism: trick or treat?","volume":"31","author":"Nagy","year":"2021","journal-title":"Thyroid"},{"key":"2026070713510445200_bib42","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s43440-022-00377-w","article-title":"Relationship between thyroid hormones and central nervous system metabolism in physiological and pathological conditions","volume":"74","author":"Sawicka-Gutaj","year":"2022","journal-title":"Pharmacol Rep"},{"key":"2026070713510445200_bib43","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1210\/clinem\/dgab808","article-title":"A longitudinal study of medial temporal lobe volumes in Graves disease","volume":"107","author":"Holmberg","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070713510445200_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fnhum.2021.739917","article-title":"Neurometabolite changes in hyperthyroid patients before and after antithyroid treatment: an in vivo 1H MRS study","volume":"15","author":"Kumar","year":"2021","journal-title":"Front Hum Neurosci"},{"key":"2026070713510445200_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.725877","article-title":"Consequences of a diagnostic label: a systematic scoping review and thematic framework","volume":"9","author":"Sims","year":"2021","journal-title":"Front Public Health"},{"key":"2026070713510445200_bib46","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1210\/clinem\/dgae140","article-title":"Hypothyroidism and type D personality: results from E-MPATHY, a cross-sectional international online patient survey","volume":"110","author":"Perros","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070713510445200_bib47","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1089\/thy.2022.0641","article-title":"Hypothyroidism and somatization: results from E-mode patient self-assessment of thyroid therapy, a cross-sectional, international online patient survey","volume":"33","author":"Perros","year":"2023","journal-title":"Thyroid"},{"key":"2026070713510445200_bib48","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1089\/thy.2017.0602","article-title":"Patients with benign thyroid diseases experience an impaired sex life","volume":"28","author":"Sawicka-Gutaj","year":"2018","journal-title":"Thyroid"},{"key":"2026070713510445200_bib49","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13044-025-00229-8","article-title":"Factors linked to poor self-rated health in thyroid disorder patients: findings from LASI Wave-I","volume":"18","author":"Kumar","year":"2025","journal-title":"Thyroid Res"},{"key":"2026070713510445200_bib50","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3390\/healthcare11050749","article-title":"Socioeconomic status and quality of life: an assessment of the mediating effect of social capital","volume":"11","author":"Nutakor","year":"2023","journal-title":"Healthcare"},{"key":"2026070713510445200_bib51","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1186\/s12905-023-02718-0","article-title":"Quality of life, social support, and adherence in female patients with thyroid disorders","volume":"23","author":"Kollerits","year":"2023","journal-title":"BMC Womens Health"},{"key":"2026070713510445200_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.115","article-title":"Quality of life is not affected by thyroid surgery in nontoxic benign goitre in long-term surveillance-a prospective observational study","volume":"3","author":"Tabriz","year":"2020","journal-title":"Endocrinol Diabetes Metab"},{"key":"2026070713510445200_bib53","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1089\/thy.1998.8.653","article-title":"Quality of life aspects and costs in treatment of Graves\u2019 hyperthyroidism with antithyroid drugs, surgery, or radioiodine: results from a prospective, randomized study","volume":"8","author":"Ljunggren","year":"1998","journal-title":"Thyroid"},{"key":"2026070713510445200_bib54","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/cen.14374","article-title":"Comparison of long-term antithyroid drugs versus radioactive iodine or surgery for Graves\u2019 disease: a review of the literature","volume":"95","author":"El Kawkgi","year":"2021","journal-title":"Clin Endocrinol"},{"key":"2026070713510445200_bib55","first-page":"22","article-title":"Recurrent goiter: risk factors, patient quality of life, and efficacy of radioiodine therapy","volume":"129","author":"Sawicka-Gutaj","year":"2019","journal-title":"Pol Arch Intern Med"},{"key":"2026070713510445200_bib56","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/cen.14873","article-title":"Body weight change trajectories following the treatment of hyperthyroidism: a prospective cohort study","volume":"98","author":"Kyriacou","year":"2023","journal-title":"Clin Endocrinol"},{"key":"2026070713510445200_bib57","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1089\/thy.2018.0731","article-title":"Patients treated for hyperthyroidism are at increased risk of becoming obese: findings from a large prospective secondary care cohort","volume":"29","author":"Torlinska","year":"2019","journal-title":"Thyroid"},{"key":"2026070713510445200_bib58","doi-asserted-by":"crossref","DOI":"10.1530\/ETJ-24-0373","article-title":"Severity of thyrotoxicosis is a risk factor for excessive weight gain in treated hyperthyroidism","volume":"14","author":"Kyriacou","year":"2025","journal-title":"Eur Thyroid J"},{"key":"2026070713510445200_bib59","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1530\/EC-21-0059","article-title":"Effect of restoration of euthyroidism on visfatin concentrations and body composition in women","volume":"10","author":"Sawicka-Gutaj","year":"2021","journal-title":"Endocr Connect"},{"key":"2026070713510445200_bib60","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1046\/j.1365-2265.2001.01329.x","article-title":"Weight gain following treatment of hyperthyroidism","volume":"55","author":"Dale","year":"2001","journal-title":"Clin Endocrinol"},{"key":"2026070713510445200_bib61","doi-asserted-by":"crossref","DOI":"10.1111\/cob.12328","article-title":"Weight gain following treatment of hyperthyroidism \u2013 a forgotten tale","volume":"9","author":"Kyriacou","year":"2019","journal-title":"Clin Obes"},{"key":"2026070713510445200_bib62","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1089\/thy.2015.0195","article-title":"Outcomes in relapsed Graves\u2019 disease patients following radioiodine or prolonged low dose of methimazole treatment","volume":"25","author":"Villagelin","year":"2015","journal-title":"Thyroid"},{"key":"2026070713510445200_bib63","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-055219","article-title":"Protocol: weight chanGes, caRdio-mEtabolic risks and morTality in patients with hyperthyroidism (EGRET): a protocol for a CPRD\u2013HES linked cohort study","volume":"11","author":"Torlinska","year":"2021","journal-title":"BMJ Open"},{"key":"2026070713510445200_bib64","doi-asserted-by":"crossref","DOI":"10.1177\/10507256251404868","article-title":"Weight gain after treatment of hyperthyroidism is associated with impairment of quality of life","author":"Kyriacou","year":"2025","journal-title":"Thyroid"},{"key":"2026070713510445200_bib65","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1530\/EJE-11-0299","article-title":"A critical review and meta-analysis of the association between overt hyperthyroidism and mortality","volume":"165","author":"Brandt","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"2026070713510445200_bib66","doi-asserted-by":"crossref","DOI":"10.1530\/ETJ-23-0010","article-title":"Patient needs and care: moves toward person-centered care for Graves\u2019 disease in Sweden","volume":"12","author":"Lindo","year":"2023","journal-title":"Eur Thyroid J"},{"key":"2026070713510445200_bib67","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s42000-019-00159-9","article-title":"Online health information-seeking behavior by endocrinology patients","volume":"18","author":"Kyriacou","year":"2019","journal-title":"Hormones"},{"key":"2026070713510445200_bib68","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1089\/thy.2013.0017","article-title":"Thyroid hormone status and health-related quality of life in the life lines cohort study","volume":"23","author":"Klaver","year":"2013","journal-title":"Thyroid"},{"key":"2026070713510445200_bib69","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1089\/thy.2011.0153","article-title":"Quality of life after surgery for Graves\u2019 disease: comparison of those having surgery intended to preserve thyroid function with those having ablative surgery","volume":"22","author":"Al-Adhami","year":"2012","journal-title":"Thyroid"},{"key":"2026070713510445200_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.surg.2024.06.063","article-title":"Improvement in thyroid-specific quality of life following radiofrequency ablation of benign thyroid nodules: a USA study","volume":"177","author":"Collins","year":"2025","journal-title":"Surgery"},{"key":"2026070713510445200_bib71","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/934595","article-title":"Radiofrequency ablation compared to surgery for the treatment of benign thyroid nodules","volume":"2014","author":"Bernardi","year":"2014","journal-title":"Int J Endocrinol"},{"key":"2026070713510445200_bib72","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3390\/medicina61030500","article-title":"Graves\u2019 disease: is it time for targeted therapy? A narrative review","volume":"61","author":"Viola","year":"2025","journal-title":"Medicina"},{"key":"2026070713510445200_bib73","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1210\/clinem\/dgae222","article-title":"A 2023 international survey of clinical practice patterns in the management of Graves disease: a decade of change","volume":"109","author":"Villagelin","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070713510445200_bib74","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ando.2023.05.002","article-title":"Metabolic complications of glucocorticoids \u2013 prevention by metformin","volume":"84","author":"Sanpawithayakul","year":"2023","journal-title":"Ann Endocrinol"},{"key":"2026070713510445200_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12968\/hmed.2025.0127","article-title":"Obesity and metabolic syndrome: current insights and future directions","volume":"86","author":"Zarkasi","year":"2025","journal-title":"Br J Hosp Med"}],"container-title":["Endocrine Connections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ec.bioscientifica.com\/view\/journals\/ec\/15\/1\/EC-25-0645.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ec.bioscientifica.com\/downloadpdf\/journals\/ec\/15\/1\/EC-25-0645.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/ec\/article-pdf\/doi\/10.1530\/EC-25-0645\/504769\/ec-25-0645.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/ec\/article-pdf\/doi\/10.1530\/EC-25-0645\/504769\/ec-25-0645.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:53:24Z","timestamp":1783446804000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/ec\/article\/15\/1\/e250645\/75333\/PERSPECTIVE-Prioritizing-quality-of-life-in-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,1]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,1]]}},"URL":"https:\/\/doi.org\/10.1530\/ec-25-0645","relation":{},"ISSN":["2049-3614"],"issn-type":[{"value":"2049-3614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,1]]},"article-number":"e250645"}}